Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04844346Terminated
Randomised, double-blind trial in obesity, sponsored by Maastricht University Medical Center+. Primary endpoint: Vaccine specific antibody titers at 4 weeks. Started Apr 2021; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04844346.